Matthias Bodenstedt Insider Trades & Stock Holdings

Chief Financial Officer · MoonLake Immunotherapeutics · Latest filing Jun 22, 2026

Matthias Bodenstedt, Chief Financial Officer at MoonLake Immunotherapeutics has 3 Form 4 trades on file since Jun 17, 2026. Open-market activity: 0 purchases ($0) and 3 sales ($1.21M), net -$1.21M. Latest filing: disposed of 39.12K shares of $MLTX on Jun 22, 2026 at $22.04.

Trades on file

3

Open-market bought

$0

Open-market sold

$1.21M

Net open-market

-$1.21M

Latest filing

Jun 22, 2026

All insider trades by Matthias Bodenstedt

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 22, 2026	$MLTX	Sell (Open-market sale) 10b5-1	39.12K	$22.04	$862.20K			-10.2%	-14.5%		Chief Financial Officer		—
Jun 18, 2026	$MLTX	Sell (Open-market sale) 10b5-1	2.79K	$19.60	$54.76K			+4.1%	-0.8%		Chief Financial Officer		Read
Jun 17, 2026	$MLTX	Sell (Open-market sale) 10b5-1	15.08K	$19.68	$296.81K			+4.2%	+2.6%		Chief Financial Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Matthias Bodenstedt traded

• $MLTX

Frequently asked questions

Has Matthias Bodenstedt been buying or selling stock?

Matthias Bodenstedt has 0 open-market purchases and 3 open-market sales on file, net -$1.21M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Matthias Bodenstedt's latest insider trade?

disposed of 39.12K shares of $MLTX on Jun 22, 2026 at $22.04.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.